AstraZeneca AB and Another v Glenmark Pharmaceuticals Europe Ltd and Others [2026] Costs LR 695
[2026] Costs LR 695
Costs of interim injunctions: whether costs reserved on interim applications should follow the ultimate outcome of the proceedings: that the unsuccessful party should pay the successful party's costs under CPR 44.2(2).
You need to log on as a current subscriber to view this report.
If you are not a subscriber, you can subscribe now online at classlegal.com.
Or call 01652 652 222.
